Dr. Michael Jensen of Seattle Children's will present the next Clinical Research Division Immunotherapy Seminar Series lecture Thursday, Nov. 10, 2-3 p.m. in Pelton Auditorium.
Jensen, director of the hospital’s Center for Childhood Cancer Research and professor of pediatrics in the University of Washington's Division of Pediatric Hematology/Oncology, will discuss "T Lymphocyte Engineering for Cancer Adoptive Therapy."
The presentation will highlight:
Former Hutchinson Center fellow
Jensen joined Seattle Children's in 2010 after spending 13 years at City of Hope, where he was director of Pediatric Cancer Program and co-leader of the Cancer Immunotherapeutics and Tumor Immunology department. In addition to authoring more than 60 research papers, Jensen is the recipient of two Young Investigator Awards and more than $2 million in research funding from the National Institutes of Health. At City of Hope he conducted the first Food and Drug Administration authorized trial of T-cell therapies for children with recurrent neuroblastoma.
Jensen studied at the University of Pennsylvania School of Medicine and completed a fellowship in pediatric hematology-oncology at the UW and the Hutchinson Center.
For more information on the CRD seminar series, send an email to email@example.com. Disability accommodations are available upon request. Please contact the ESC help desk at firstname.lastname@example.org or (206) 667-4700.